MedTrace Logo

MitraClip® After Surgical Mitral Valve Repair

NCT02853955 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2016-09-01

No results posted yet for this study

Summary

Percutaneous edge-to-edge repair of the mitral valve has been shown to be a safe and effective alternative treatment option for selected patients at high risk for cardiac surgery. Patients with recurrent mitral regurgitation after surgical mitral valve repair (sMVR) are per se at increased risk for another cardiac surgery. The purpose of this multicenter retrospective analysis of patients treated with a MitraClip® after sMVR, is to evaluate the effectiveness and durability of this minimally invasive treatment option in this subset of patients.

Conditions

  • Mitral Regurgitation

Interventions

DEVICE

Percutaneous edge-to-edge repair of the mitral valve

MitraClip in patients with recurrent MI after surgical mitral valve repair.

Sponsors & Collaborators

  • LMU Klinikum

    lead OTHER

Principal Investigators

  • Jörg Hausleiter, MD · LMU Munich

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2016-09-30
Completion
2016-11-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02853955 on ClinicalTrials.gov